You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic hormone sensitive prostate cancer; abiraterone; metformin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Prostate Cancer Trial in Guangzhou (Metformin)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 8, 2021

Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • (no location specified)
Nov 10, 2023

Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • Chicago, Illinois
    Northwestern University
Sep 27, 2023

High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Trial (dalpiciclib isethionate tablets; abiraterone acetate

Not yet recruiting
  • High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
  • dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets
  • placebo; abiraterone acetate tablets; prednisone tablets
  • (no location specified)
Oct 20, 2023

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Bronx, New York
    Montefiore Medical Center
Sep 22, 2022

Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

Recruiting
  • Prostate Cancer
  • Stage IV Prostate Cancer
  • Luteinizing Hormone Releasing Hormone
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 1, 2022

Learn More About How Safe Darolutamide is Under Real-world

Not yet recruiting
  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
  • No Intervention
  • Multiple Locations, Japan
    Many Locations
Aug 24, 2023

Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemo Effect Trial in Nanjing (Docetaxel, Rezvilutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Nanjing, Jiangsu, China
    Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
Aug 2, 2023

Apalutamide in Metastatic Hormone Sensitive Prostate Cancer

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    • Cardiff, United Kingdom
    • +4 more
    Aug 25, 2023

    Learn About Novel Hormonal Therapies in People With Metastatic

    Not yet recruiting
    • Prostatic Neoplasms
    • Novel hormonal therapy
    • New York, New York
      Pfizer Inc
    Oct 2, 2023

    Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

    Recruiting
    • Prostate Cancer Metastatic
    • Prostate Cancer
    • Houston, Texas
    • +2 more
    Oct 7, 2022

    Prostate Cancer, Radiotherapy Side Effect, Metastatic Cancer Trial in Umeå (Moderate hypo-fractionation,

    Recruiting
    • Prostate Cancer
    • +2 more
    • Moderate hypo-fractionation
    • Ultra-hypo-fractionation
    • Umeå, Sweden
      Cancercenter University hospital of Umeå
    Nov 1, 2022

    Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

    Active, not recruiting
    • Castration-Sensitive Prostate Carcinoma
    • +7 more
    • Antiandrogen Therapy
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 8, 2022

    Prostate Cancer Trial (Dutasteride, Abiraterone)

    Not yet recruiting
    • Prostate Cancer
    • (no location specified)
    Jan 30, 2023

    Metastatic Prostate Cancer in Pirkanmaa Hospital District in

    Not yet recruiting
    • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
    • Metastatic Castration Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 17, 2023

    Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

    Not yet recruiting
    • Oligometastatic Hormone Sensitive Prostate Cancer
    • SBRT on all sites of metastatic disease+Apalutamide
    • Florence, Italy
      AOU Careggi Radiation Oncology Unit
    Jan 29, 2023

    Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)

    Not yet recruiting
    • Metastatic Cancer
    • Neoplasm, Prostate
    • Abiraterone acetate
    • +2 more
    • Bronx, New York
      James J. Peters VA Medical Center
    Jun 16, 2022

    Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

    Active, not recruiting
    • Metastatic Prostate Carcinoma
    • +5 more
    • Abiraterone Acetate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 26, 2022

    Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

    Recruiting
    • Prostate Cancer
    • Prostate Cancer Metastatic
    • La Jolla, California
    • +1 more
    Feb 2, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • Prostatic Neoplasms
    • (no location specified)
    Nov 21, 2023

    Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

    Recruiting
    • Hormone Sensitive Metastatic Prostate Cancer
    • +3 more
    • Nanjing, Jiangsu, China
      Department of Urology, Drum Tower Hospital, Medical School of Na
    Jul 13, 2022

    Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta

    Not yet recruiting
    • Castration-Sensitive Prostate Carcinoma
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Feb 8, 2023

    Learn About Novel Hormonal Therapies for Metastatic

    Not yet recruiting
    • Prostatic Neoplasms
    • Novel hormonal therapy
    • New York, New York
      Pfizer Inc
    Nov 21, 2023

    Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

    Recruiting
    • Castration-Sensitive Prostate Carcinoma
    • +4 more
    • Abiraterone Acetate
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Oct 7, 2022